Generics
Lannett reports issuance of USD75m convertible senior notes
25 September 2019 - Lannett Company Inc (NYSE:LCI), a provider of generic pharmaceutical products, said on Tuesday that it plans to issue USD75m aggregate principal amount of convertible senior notes ...
Hovione outlines Phase 3 Programme for Minocycline Topical Gel upon successful End-of-phase 2 meeting with FDA
23 September 2019 - Drug product development company Hovione on Friday provided an update of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development programme for treatin...
Dr. Reddy's Launches Over-the-Counter, Store-Brand Equivalent of Prevacid 24HR Capsules in the US Market
18 September 2019 - - Indian drugmaker Dr. Reddy's Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) has launched Lansoprazole Delayed-Release Capsules USP, 15 mg, an over-the-counter st...
Meitheal Pharmaceuticals Launches Heparin Sodium Injection, USP in the United States
17 September 2019 - - US-based generic injectables company Meitheal Pharmaceuticals has launched its eight presentations of heparin sodium injection, USP in the United States, the company said.
...
Xellia Pharmaceuticals Names Baker as Chief Commercial Officer of Xellia North America
16 September 2019 - - Denmark-based specialty anti-infective treatments manufacturer Xellia Pharmaceuticals has appointed Peter Baker as chief commercial officer for Xellia North America, the company ...
Dr. Reddy's Laboratories Launches Fosaprepitant for Injection in the US Market
13 September 2019 - - Indian pharmaceutical company Dr. Reddy's Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) has launched Fosaprepitant for Injection, the therapeutic generic equiva...